share_log

Biogen Shares Slip 6.7% as EU Rejects Alzheimer's Drug

Biogen Shares Slip 6.7% as EU Rejects Alzheimer's Drug

渤健公司的股票下跌了6.7%,因爲歐盟拒絕了治療阿爾茨海默病的藥物。
Barron's ·  07/26 11:05  · 異動

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論